Article

Obstructive sleep apnea worsens diabetic retinopathy

Author(s):

Lynda Charters

Philadelphia-Obstructive sleep apnea appears to be a significant, previously unrecognized aggravating factor in diabetic retinopathy that promotes progression of ischemia and edema, according to Stephen Sinclair, MD, clinical professor, Hahnemann University Hospital, Philadelphia.

Related Videos
(Image credit: Ophthalmology Times) Neda Shamie_Controversies in Modern Eye Care 2025
(Image credit: Ophthalmology Times) World Cornea Congress IX: Epi-on and accelerated crosslinking with Kenneth Beckman, MD
(Image credit: Ophthalmology Times) The synergy of cornea, cataract, and refractive surgery through the decades: insights from George O. Waring IV, MD
(Image credit: Ophthalmology Times) AGS 2025: A look at Gemini and the MIGS revolution with Mona Kaleem, MD
(Image credit: Ophthalmology Times) AGS 2025: Development and evaluation of an AI model to set target IOP with Jithin Yohannan, MD, MPH
(Image credit: Ophthalmology Times) NeuroOp Guru: The role of muscle biopsy in heteroplasmy detection
Related Content
Myopia onset predicted by accelerated eye changes a year in advance
April 2nd 2025

Myopia onset predicted by accelerated eye changes a year in advance

2025 Glaucoma 360 brings celebration, innovation, and education to San Francisco
December 13th 2024

California dreaming: 2025 Glaucoma 360 brings celebration, innovation, and education to San Francisco

Economic burden of late-stage age-related macular degeneration
April 1st 2025

Economic burden of late-stage age-related macular degeneration

EnVision Summit 2025: Advancing Ophthalmology and Optometry Together
November 19th 2024

Connect, learn, and innovate in a family-friendly atmosphere: What to expect at EnVision Summit 2025

Prevent Blindness declares April as Women’s Eye Health and Safety Month
April 1st 2025

Prevent Blindness declares April as Women’s Eye Health and Safety Month

OKYO Pharma releases positive long-term stability data for urcosimod in neuropathic corneal pain
March 31st 2025

OKYO Pharma releases positive long-term stability data for urcosimod in neuropathic corneal pain

© 2025 MJH Life Sciences

All rights reserved.